Rabia Ozden

Rabia Ozden

Plus aucun poste en cours
58 ans
Health Technology
Consumer Services
Commercial Services

Profil

Rabia Gurses Ozden worked as Executive Medical Director-Ophthalmology at Quark Pharmaceuticals, Inc. from 2011 to 2014.
The role of Vice President & Head-Clinical Ophthalmology was held at GSK Plc.
From 2015 to 2018, the position of Vice President-Clinical Research & Development was at Beacon Therapeutics (USA), Inc. Served as Assistant Professor at New York Medical College.
In 2019, the role of Chief Medical Officer was at Nightstar Therapeutics Ltd. From 2019 to 2021, Chief Development Officer was at Akouos, Inc. Chief Medical Officer roles were held at Ocular Therapeutix, Inc. from 2022 to 2024 and at Adverum Biotechnologies, Inc. from 2024 to 2025.
Education includes a doctorate degree from Hacettepe University.

Anciens postes connus de Rabia Ozden

SociétésPosteFin
ADVERUM BIOTECHNOLOGIES, INC. Directeur Technique/Scientifique/R&D 09/12/2025
OCULAR THERAPEUTIX, INC. Directeur Technique/Scientifique/R&D 20/05/2024
AKOUOS Corporate Officer/Principal 01/01/2021
NIGHTSTAR THERAPEUTICS PLC Directeur Technique/Scientifique/R&D 01/12/2019
APPLIED GENETIC TECHNOLOGIES CORPORATION Directeur Technique/Scientifique/R&D 01/03/2018
Voir l'expérience en détail de Rabia Ozden

Formation de Rabia Ozden

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

24

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Rabia Ozden
🔇